...
首页> 外文期刊>BMC Microbiology >A novel inhibitor of Chlamydophila pneumoniae protein kinase D (PknD) inhibits phosphorylation of CdsD and suppresses bacterial replication
【24h】

A novel inhibitor of Chlamydophila pneumoniae protein kinase D (PknD) inhibits phosphorylation of CdsD and suppresses bacterial replication

机译:肺炎衣原体蛋白激酶D(PknD)的新型抑制剂可抑制CdsD的磷酸化并抑制细菌复制

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background We have shown previously that Chlamydophila pneumoniae contains a dual-specific Ser/Thr protein kinase that phosphorylates CdsD, a structural component of the type III secretion apparatus. To further study the role of PknD in growth and development we sought to identify a PknD inhibitor to determine whether PknD activity is required for replication. Results Using an in vitro kinase assay we screened 80 known eukaryotic protein kinase inhibitors for activity against PknD and identified a 3'-pyridyl oxindole compound that inhibited PknD autophosphorylation and phosphorylation of CdsD. The PknD inhibitor significantly retarded the growth rate of C. pneumoniae as evidenced by the presence of very small inclusions with a reduced number of bacteria as seen by electron microscopy. These inclusions contained the normal replicative forms including elementary bodies (EB), intermediate bodies (IB) and reticulate bodies (RB), but lacked persistent bodies (PB), indicating that induction of persistence was not the cause of reduced chlamydial growth. Blind passage of C. pneumoniae grown in the presence of this PknD inhibitor for 72 or 84 hr failed to produce inclusions, suggesting this compound blocks an essential step in the production of infectious chlamydial EB. The compound was not toxic to HeLa cells, did not block activation of the MEK/ERK pathway required for chlamydial invasion and did not block intracellular replication of either Chlamydia trachomatis serovar D or Salmonella enterica sv. Typhimurium suggesting that the inhibitory effect of the compound is specific for C. pneumoniae. Conclusion We have identified a 3'-pyridyl oxindole compound that inhibits the in vitro kinase activity of C. pneumoniae PknD and inhibits the growth and production of infectious C. pneumoniae progeny in HeLa cells. Together, these results suggest that PknD may play a key role in the developmental cycle of C. pneumoniae.
机译:背景技术我们以前已经证明肺炎衣原体含有双重特异性的Ser / Thr蛋白激酶,该蛋白激酶使CdsD磷酸化,CdsD是III型分泌设备的结构成分。为了进一步研究PknD在生长和发育中的作用,我们试图鉴定PknD抑制剂来确定复制是否需要PknD活性。结果使用体外激酶测定法,我们筛选了80种已知的真核蛋白激酶抑制剂对PknD的活性,并鉴定了可抑制PknD自磷酸化和CdsD磷酸化的3'-吡啶基羟吲哚化合物。 PknD抑制剂显着阻碍了肺炎衣原体的生长速度,如通过电子显微镜观察到的那样,存在极少量的夹杂物和细菌数量减少证明了这一点。这些内含物包含正常的复制形式,包括基本体(EB),中间体(IB)和网状体(RB),但缺少持久性体(PB),这表明持久性的诱导不是衣原体生长减少的原因。在该PknD抑制剂存在下生长72或84 hr的肺炎衣原体的盲传未能产生内含物,这表明该化合物阻断了感染性衣原体EB的生产中必不可少的步骤。该化合物对HeLa细胞无毒,不会阻断衣原体入侵所需的MEK / ERK途径的活化,也不会阻断沙眼衣原体血清型D或肠炎沙门氏菌的细胞内复制。鼠伤寒表明该化合物对肺炎衣原体具有抑制作用。结论我们已经确定了一种3'-吡啶基羟吲哚化合物,该化合物可抑制肺炎衣原体PknD的体外激酶活性,并抑制HeLa细胞中感染性肺炎衣原体的生长和产生。在一起,这些结果表明PknD可能在肺炎衣原体的发展周期中发挥关键作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号